Search
for

    Glossary Steroid-Resistant Alopecia Areata

    hair loss condition unresponsive to standard corticosteroid treatments

    Steroid-Resistant Alopecia Areata is a form of alopecia areata where the hair loss condition does not respond to standard corticosteroid treatments, which are typically used to reduce inflammation and suppress the immune system. This resistance can make the condition more challenging to manage, often requiring alternative therapies such as immunotherapy, biologics, or other systemic treatments.

    Related Terms

    Research 10 of 1000+

    1. Potential Treatment of Steroid‐Resistant Alopecia Areata Using Allogeneic Exosomes Derived From Adipose Tissue Mesenchymal Stromal Cells: A Case Report Clinical Case Reports · 2026
    2. Treatment of Steroid-Resistant Beard-Restricted Alopecia Areata with Baricitinib Skin · 2024
    3. Successful treatment of corticosteroid-resistant ophiasis-type alopecia areata (AA) with platelet-rich plasma (PRP) JAAD case reports · 2015 · 30 citations
    4. Resistance of Transplanted Hair Follicles to the Onslaught of Diffuse Alopecia Areata The American Journal of Cosmetic Surgery · 2017
    5. Contact immunotherapy‐resistant alopecia areata totalis/universalis reactive to topical corticosteroid The Journal of Dermatology · 2015 · 5 citations
    6. Scalp roller therapy in resistant alopecia areata Journal of Cutaneous and Aesthetic Surgery · 2014 · 14 citations
    7. Alopecia areata and relapsing polychondritis or mosaic autoimmunity? The first experience of co-trimoxazole treatment Annals of the Rheumatic Diseases · 2003 · 13 citations
    8. A Real-World Study of Steroid-Free Monotherapy with Tofacitinib in Severe and Therapy-Recalcitrant Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Cases: A Retrospective Analysis Indian Dermatology Online Journal · 2023
    9. Cyclosporine-Induced Alopecia in Childhood Nephrotic Syndrome – A Case Report Journal of Nepal Paediatric Society · 2024 · 1 citations
    10. Recalcitrant alopecia areata responsive to leflunomide and anthralin—Potentially undiscovered JAK/STAT inhibitors? Pediatric dermatology · 2018 · 11 citations
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →